12-187
Showing 1 - 25 of >10,000
Acute Lymphoid Leukemia Trial in Spain (ARI-0001 cells)
Recruiting
- Acute Lymphoid Leukemia
- ARI-0001 cells
-
Badalona, Barcelona, Spain
- +9 more
Feb 3, 2022
SARS-CoV-2 Virus Infection Trial in United Kingdom (VLA2001, AZD1222, VLA2001 - adolescent part)
Active, not recruiting
- SARS-CoV-2 Virus Infection
- VLA2001
- +3 more
-
Barnsley, United Kingdom
- +30 more
Oct 17, 2022
Ulcerative Colitis Trial in Japan (Etrasimod, Placebo)
Recruiting
- Ulcerative Colitis
- Etrasimod
- Placebo
-
Toyohashi-shi, Aichi- KEN, Japan
- +70 more
Jan 3, 2023
Duchenne Muscular Dystrophy Trial in Worldwide (PF-06939926, Placebo)
Recruiting
- Duchenne Muscular Dystrophy
- PF-06939926
- Placebo
-
Little Rock, Arkansas
- +54 more
Jan 18, 2023
Aggressive Prostate Cancer in Real Life: Initiation, Schedule
Completed
- Prostate Cancer
-
Paris, FranceIpsen Central Contact
Dec 20, 2022
Schizophrenia, Schizoaffective Disorder Trial in Worldwide (RO6889450, Placebo)
Recruiting
- Schizophrenia, Schizoaffective Disorder
- RO6889450
- Placebo
-
Bellflower, California
- +65 more
Feb 2, 2023
Progressive Supranuclear Palsy (PSP) Trial in Worldwide (ABBV-8E12, Placebo solution for IV infusion on Day 15)
Terminated
- Progressive Supranuclear Palsy (PSP)
- ABBV-8E12
- Placebo solution for IV infusion on Day 15
-
Birmingham, Alabama
- +41 more
Feb 1, 2021
Multichannel ECG Analytic System in Cardiovascular Diseases
Recruiting
- Multichannel ECG System
-
Taipei, TaiwanNTUH
Mar 24, 2022
187 Critically Ill Coronavirus Disease 2019 (COVID-19)
Completed
- COVID-19
- demographic and clinical data obtained from hospital's electronic medical record.
-
Sao Luis, MA, BrazilHospital Sao Domingos
Mar 14, 2022
Duchenne Muscular Dystrophy Trial in Worldwide (RO7239361, Placebo for RO7239361)
Completed
- Duchenne Muscular Dystrophy
- RO7239361
- Placebo for RO7239361
-
Phoenix, Arizona
- +43 more
Nov 25, 2020
Progressive Supranuclear Palsy Trial in Worldwide (Placebo, ABBV-8E12)
Terminated
- Progressive Supranuclear Palsy
- Placebo
- ABBV-8E12
-
Birmingham, Alabama
- +65 more
Feb 1, 2021
Smallpox, Monkeypox, Cowpox Trial in Novosibirsk (VAC?6 vaccine - ?nce at a dose of 106 PFU, VAC?6 vaccine - once at a dose of
Completed
- Smallpox
- +3 more
- VAC∆6 vaccine - оnce at a dose of 10⁶ PFU
- +3 more
-
Novosibirsk, Koltsovo, Novosibirsk Region, Russian FederationFederal State Budgetary Healthcare Institution - Medical and San
Feb 28, 2023
Infant Development, Safety Issues Trial in Madrid (Infant formula supplemented with Bifidobacterium breve PS1, Infant formula
Completed
- Infant Development
- Safety Issues
- Infant formula supplemented with Bifidobacterium breve PS1
- Infant formula NOT supplemented with Bifidobacterium breve PS1
-
Madrid, Spain
- +2 more
Jul 25, 2023
Parkinson's Disease (PD) Trial in Worldwide (Optimized antiparkinsonian treatment, Levodopa-Carbidopa Intestinal Gel (LCIG),
Completed
- Parkinson's Disease (PD)
- Optimized antiparkinsonian treatment
- +4 more
-
Port Charlotte, Florida
- +27 more
Aug 10, 2020
Dedifferentiated Liposarcoma Trial in Worldwide (Selinexor, Placebo)
Completed
- Dedifferentiated Liposarcoma
- Selinexor
- Placebo
-
Los Angeles, California
- +70 more
Jan 5, 2023
Otitis Media, Tonsillitis, Pharyngitis Trial in Germany, Poland (Clarithromycin DST (125 mg), Clarithromycin DST (187.5 mg),
Completed
- Otitis Media
- +3 more
- Clarithromycin DST (125 mg)
- +5 more
-
Balve, Germany
- +19 more
Jul 10, 2019
Chronic Fatigue Syndrome, COVID-19, Long Haul Trial in Warsaw (Pregabalin, Independent walking training, Placebo)
Recruiting
- Chronic Fatigue Syndrome
- COVID-19, Long Haul
- Pregabalin
- +5 more
-
Warsaw, Mazowieckie, PolandCentrum Wsparcia Badań Klinicznych
Jul 31, 2023
Cardiac Rehabilitation of Children and Long QT Syndrome
Active, not recruiting
- Long QT Syndrome
- +3 more
-
Montpellier, France
- +1 more
Jul 19, 2023
Olfactory Disorder Trial in Saint Louis (Smell training)
Completed
- Olfactory Disorder
- Smell training
-
Saint Louis, MissouriWashington University
Nov 3, 2022
Rheumatoid Arthritis Trial in Worldwide (Upadacitinib, Pneumococcal 13-valent conjugate vaccine (PCV-13))
Completed
- Rheumatoid Arthritis
- Upadacitinib
- Pneumococcal 13-valent conjugate vaccine (PCV-13)
-
Huntsville, Alabama
- +123 more
Jun 15, 2022
Quadriplegic Cerebral Palsy Trial in Reggio Emilia (postural management)
Recruiting
- Quadriplegic Cerebral Palsy
- postural management
-
Reggio Emilia, ItalyAzienda Unità Sanitaria Locale Reggio Emilia
Nov 14, 2022
Schizophrenia Trial in Worldwide (BI 425809 dose 1, BI 425809 dose 2, BI 425809 dose 3)
Completed
- Schizophrenia
- BI 425809 dose 1
- +4 more
-
Garden Grove, California
- +80 more
Feb 5, 2021
COVID-19, SARS-CoV-2 Infection Trial (SCTV01C, SCTV01E, Sinopharm inactivated COVID-19 vaccine)
Not yet recruiting
- COVID-19
- SARS-CoV-2 Infection
- SCTV01C
- +3 more
- (no location specified)
Apr 1, 2022